#METABOLOMICS WORKBENCH leaptrkl_20220826_093946 DATATRACK_ID:3434 STUDY_ID:ST002268 ANALYSIS_ID:AN003705 PROJECT_ID:PR001450
VERSION             	1
CREATED_ON             	August 26, 2022, 11:32 am
#PROJECT
PR:PROJECT_TITLE                 	Autophagy-related protein PIK3C3 maintains healthy brown and white adipose
PR:PROJECT_TITLE                 	tissues to prevent metabolic diseases
PR:PROJECT_TYPE                  	Lipidomics
PR:PROJECT_SUMMARY               	Adequate mass and function of adipose tissues (ATs) play an essential role in
PR:PROJECT_SUMMARY               	preventing metabolic perturbations. Pathological reduction of ATs in
PR:PROJECT_SUMMARY               	lipodystrophy leads to an array of metabolic diseases. Understanding the
PR:PROJECT_SUMMARY               	underlying mechanisms may benefit the development of effective therapies.
PR:PROJECT_SUMMARY               	Several cellular processes, including autophagy, function collectively to
PR:PROJECT_SUMMARY               	maintain AT homeostasis. Here, we investigated the impact of adipocyte-specific
PR:PROJECT_SUMMARY               	deletion of the autophagy-related lipid kinase PIK3C3 on AT homeostasis and
PR:PROJECT_SUMMARY               	systemic metabolism in mice. We report that PIK3C3 functions in all ATs and that
PR:PROJECT_SUMMARY               	its absence disturbs adipocyte autophagy and hinders adipocyte differentiation,
PR:PROJECT_SUMMARY               	survival, and function with differential effects on brown and white ATs. These
PR:PROJECT_SUMMARY               	abnormalities caused loss of white ATs, whitening followed by loss of brown ATs,
PR:PROJECT_SUMMARY               	and impaired browning of white ATs. Consequently, mice exhibited compromised
PR:PROJECT_SUMMARY               	thermogenic capacity and developed dyslipidemia, hepatic steatosis, insulin
PR:PROJECT_SUMMARY               	resistance and type 2 diabetes. While these effects of PIK3C3 contrast previous
PR:PROJECT_SUMMARY               	findings with the autophagy-related protein ATG7 in adipocytes, mice with a
PR:PROJECT_SUMMARY               	combined deficiency in both factors revealed a dominant role of the
PR:PROJECT_SUMMARY               	PIK3C3-deficient phenotype. We also found that dietary lipid excess exacerbates
PR:PROJECT_SUMMARY               	AT pathologies caused by PIK3C3 deficiency. Surprisingly, glucose tolerance was
PR:PROJECT_SUMMARY               	spared in adipocyte-specific PIK3C3-deficient mice, a phenotype that was more
PR:PROJECT_SUMMARY               	evident during dietary lipid excess. These findings reveal a crucial yet complex
PR:PROJECT_SUMMARY               	role for PIK3C3 in ATs and suggest the potential of targeting this factor for
PR:PROJECT_SUMMARY               	therapeutic intervention in metabolic diseases.
PR:INSTITUTE                     	Vanderbilt University
PR:DEPARTMENT                    	Chemistry
PR:LABORATORY                    	Center for Innovative Technology
PR:LAST_NAME                     	Leaptrot
PR:FIRST_NAME                    	Katrina
PR:ADDRESS                       	1234 Stevenson Center Ln
PR:EMAIL                         	katrina.l.leaptrot@vanderbilt.edu
PR:PHONE                         	6158758422
#STUDY
ST:STUDY_TITLE                   	Autophagy-related protein PIK3C3 maintains healthy brown and white adipose
ST:STUDY_TITLE                   	tissues to prevent metabolic diseases
ST:STUDY_TYPE                    	Lipidomics
ST:STUDY_SUMMARY                 	Adequate mass and function of adipose tissues (ATs) play an essential role in
ST:STUDY_SUMMARY                 	preventing metabolic perturbations. Pathological reduction of ATs in
ST:STUDY_SUMMARY                 	lipodystrophy leads to an array of metabolic diseases. Understanding the
ST:STUDY_SUMMARY                 	underlying mechanisms may benefit the development of effective therapies.
ST:STUDY_SUMMARY                 	Several cellular processes, including autophagy, function collectively to
ST:STUDY_SUMMARY                 	maintain AT homeostasis. Here, we investigated the impact of adipocyte-specific
ST:STUDY_SUMMARY                 	deletion of the autophagy-related lipid kinase PIK3C3 on AT homeostasis and
ST:STUDY_SUMMARY                 	systemic metabolism in mice. We report that PIK3C3 functions in all ATs and that
ST:STUDY_SUMMARY                 	its absence disturbs adipocyte autophagy and hinders adipocyte differentiation,
ST:STUDY_SUMMARY                 	survival, and function with differential effects on brown and white ATs. These
ST:STUDY_SUMMARY                 	abnormalities caused loss of white ATs, whitening followed by loss of brown ATs,
ST:STUDY_SUMMARY                 	and impaired browning of white ATs. Consequently, mice exhibited compromised
ST:STUDY_SUMMARY                 	thermogenic capacity and developed dyslipidemia, hepatic steatosis, insulin
ST:STUDY_SUMMARY                 	resistance and type 2 diabetes. While these effects of PIK3C3 contrast previous
ST:STUDY_SUMMARY                 	findings with the autophagy-related protein ATG7 in adipocytes, mice with a
ST:STUDY_SUMMARY                 	combined deficiency in both factors revealed a dominant role of the
ST:STUDY_SUMMARY                 	PIK3C3-deficient phenotype. We also found that dietary lipid excess exacerbates
ST:STUDY_SUMMARY                 	AT pathologies caused by PIK3C3 deficiency. Surprisingly, glucose tolerance was
ST:STUDY_SUMMARY                 	spared in adipocyte-specific PIK3C3-deficient mice, a phenotype that was more
ST:STUDY_SUMMARY                 	evident during dietary lipid excess. These findings reveal a crucial yet complex
ST:STUDY_SUMMARY                 	role for PIK3C3 in ATs and suggest the potential of targeting this factor for
ST:STUDY_SUMMARY                 	therapeutic intervention in metabolic diseases.
ST:INSTITUTE                     	Vanderbilt University
ST:DEPARTMENT                    	Chemistry
ST:LABORATORY                    	Center for Innovative Technology
ST:LAST_NAME                     	Leaptrot
ST:FIRST_NAME                    	Katrina
ST:ADDRESS                       	1234 Stevenson Center Ln
ST:EMAIL                         	katrina.l.leaptrot@vanderbilt.edu
ST:PHONE                         	6158758422
ST:NUM_GROUPS                    	4
ST:TOTAL_SUBJECTS                	16
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
SU:GENOTYPE_STRAIN               	Pik3c3f/f mice
SU:AGE_OR_AGE_RANGE              	W24
SU:GENDER                        	Male and female
SU:ANIMAL_ANIMAL_SUPPLIER        	Jackson Laboratory
SU:ANIMAL_HOUSING                	pathogen-free conditions at a controlled room temperature
SU:ANIMAL_LIGHT_CYCLE            	12-hour light/dark cycle
SU:ANIMAL_FEED                   	regular chow diet (5LOD, LabDiet)
SU:ANIMAL_WATER                  	ad lib
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	S1	BAT-WT-S1	Genotype:WT | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_13_FS_S1_pos.d
SUBJECT_SAMPLE_FACTORS           	S2	BAT-WT-S2	Genotype:WT | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_11_FS_S2_pos.d
SUBJECT_SAMPLE_FACTORS           	S3	BAT-WT-S3	Genotype:WT | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_16_FS_S3_pos.d
SUBJECT_SAMPLE_FACTORS           	S4	BAT-WT-S4	Genotype:WT | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_15_FS_S4_pos.d
SUBJECT_SAMPLE_FACTORS           	S5	BAT-KO-S5	Genotype:KO | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_25_FS_S5_pos.d
SUBJECT_SAMPLE_FACTORS           	S6	BAT-KO-S6	Genotype:KO | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_08_FS_S6_pos.d
SUBJECT_SAMPLE_FACTORS           	S7	BAT-KO-S7	Genotype:KO | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_18_FS_S7_pos.d
SUBJECT_SAMPLE_FACTORS           	S8	BAT-KO-S8	Genotype:KO | Lipid Type:Brown adipose tissue	RAW_FILE_NAME=20220131_KLL_23_FS_S8_pos.d
SUBJECT_SAMPLE_FACTORS           	S9	VAT-WT-S9	Genotype:WT | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_27_FS_S9_pos.d
SUBJECT_SAMPLE_FACTORS           	S10	VAT-WT-S10	Genotype:WT | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_20_FS_S10_pos.d
SUBJECT_SAMPLE_FACTORS           	S11	VAT-WT-S11	Genotype:WT | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_09_FS_S11_pos.d
SUBJECT_SAMPLE_FACTORS           	S12	VAT-WT-S12	Genotype:WT | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_24_FS_S12_pos.d
SUBJECT_SAMPLE_FACTORS           	S13	VAT-KO-S13	Genotype:KO | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_26_FS_S13_pos.d
SUBJECT_SAMPLE_FACTORS           	S14	VAT-KO-S14	Genotype:KO | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_14_FS_S14_pos.d
SUBJECT_SAMPLE_FACTORS           	S15	VAT-KO-S15	Genotype:KO | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_10_FS_S15_pos.d
SUBJECT_SAMPLE_FACTORS           	S16	VAT-KO-S16	Genotype:KO | Lipid Type:White adipose tissue	RAW_FILE_NAME=20220131_KLL_21_FS_S16_pos.d
#COLLECTION
CO:COLLECTION_SUMMARY            	Mice were housed under specific pathogen-free conditions, fed with a regular
CO:COLLECTION_SUMMARY            	chow diet (5LOD, LabDiet), provided food and water ad lib unless otherwise
CO:COLLECTION_SUMMARY            	specified, and maintained on a 12-hour light/dark cycle at a controlled room
CO:COLLECTION_SUMMARY            	temperature of 22°C, except for the cold treatment studies. Mice were
CO:COLLECTION_SUMMARY            	sacrificed at non-fasting state for further analysis unless otherwise specified.
CO:COLLECTION_PROTOCOL_FILENAME  	Materials and Methods.pdf
CO:SAMPLE_TYPE                   	Adipose tissue
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	We generated Adipoq-Cre;Pik3c3f/f (cKO) and Pik3c3f/f (WT) mice and analyzed
TR:TREATMENT_SUMMARY             	interscapular BAT (iBAT), inguinal subcutaneous WAT (iWAT), and perigonadal
TR:TREATMENT_SUMMARY             	visceral WAT (pWAT).
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	The iBAT and pWAT was harvestedat sacrifice from mice at W24. Samples were
SP:SAMPLEPREP_SUMMARY            	immediately frozen in liquid nitrogen followed by -80°C storage before
SP:SAMPLEPREP_SUMMARY            	analysis. Both WT (n=4) and cKO (n=4) mice were analyzed. Adipose tissue
SP:SAMPLEPREP_SUMMARY            	samples, ranging from 10-30 mg, were thawed on ice and mixed with 1 mL of cold
SP:SAMPLEPREP_SUMMARY            	1:1:2 (v:v:v) methanol MeOH:ACN:H2O with 50 mM ammonium bicarbonate lysis
SP:SAMPLEPREP_SUMMARY            	buffer. Samples were homogenized using a tissue homogenizer operated at 20,000
SP:SAMPLEPREP_SUMMARY            	rpm for 10 seconds to break the tissue, then vortex mixed for 10 seconds. An
SP:SAMPLEPREP_SUMMARY            	appropriate volume of lysate was transferred from each sample such that
SP:SAMPLEPREP_SUMMARY            	individual samples were normalized based on tissue amount. Following volume
SP:SAMPLEPREP_SUMMARY            	adjustment to 200 L, 800 L of cold MeOH was added to the samples.
SP:SAMPLEPREP_SUMMARY            	Individual samples were vortexed for 30 seconds and incubated overnight at
SP:SAMPLEPREP_SUMMARY            	-80°C for protein precipitation. Following incubation, samples were centrifuged
SP:SAMPLEPREP_SUMMARY            	for 15 min at 15,000 rpm at 4°C and the supernatant was transferred to a new
SP:SAMPLEPREP_SUMMARY            	labeled tube and dried down using a cold vacuum centrifuge. Samples were
SP:SAMPLEPREP_SUMMARY            	reconstituted in 100 L H2O, 100 L MeOH, and 10 μL of SPLASH LIPIDOMIX
SP:SAMPLEPREP_SUMMARY            	with vortex mixing after each addition. Samples were incubated at room
SP:SAMPLEPREP_SUMMARY            	temperature for 10 min followed
SP:SAMPLEPREP_PROTOCOL_FILENAME  	Global untargeted lipidomics.pdf
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 6560
CH:COLUMN_NAME                   	Thermo Hypersil Gold column (1.9 M, 2.1 mm x 100 mm)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6560 Ion Mobility
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	Data analysis was performed using Progenesis QI software (version 3.0, Nonlinear
MS:MS_COMMENTS                   	Dynamics, Newcastle, UK). Retention time alignment, peak picking, and peak
MS:MS_COMMENTS                   	deconvolution used default parameters. Spectra were normalized to all compounds,
MS:MS_COMMENTS                   	and data were filtered for coefficients of variance < 25% in QC technical
MS:MS_COMMENTS                   	replicate injections. A prioritized compound list was generated via a one-factor
MS:MS_COMMENTS                   	ANOVA, with four experimental groups for comparison including wild type and
MS:MS_COMMENTS                   	Vps34 knockout for both brown and visceral adipose tissue. Lipids were
MS:MS_COMMENTS                   	considered to be differentially altered if the p-value < 0.05 and the fold
MS:MS_COMMENTS                   	change was greater than Ι2Ι. Significantly changed compounds were selected for
MS:MS_COMMENTS                   	annotation. Lipidomic annotations were performed using a previously described
MS:MS_COMMENTS                   	classification system with compounds being assigned a confidence level of 1 to 5
MS:MS_COMMENTS                   	(1 being the highest confidence) with improved confidence requiring more
MS:MS_COMMENTS                   	supporting evidence such as accurate mass, MS/MS fragmentation, and retention
MS:MS_COMMENTS                   	time matching to standards. Lipid annotated were performed with reference to
MS:MS_COMMENTS                   	in-house and online databases (MS-DIAL, LipidMatch, and Lipid Annotator).
MS:MS_COMMENTS                   	Differentially abundant lipids (DALs) were uploaded into the LIPEA algorithm for
MS:MS_COMMENTS                   	pathway enrichment analysis. Corrected p-values were calculated using Benjamini
MS:MS_COMMENTS                   	correction and a p-value <0.05 was used to determine significantly affected
MS:MS_COMMENTS                   	pathways.
MS:MS_RESULTS_FILE               	ST002268_AN003705_Results.txt	UNITS:retention time underscore m/z	Has m/z:Yes	Has RT:Yes	RT units:Minutes
#END